Posted by Michael Wonder on 14 Dec 2021
PHARMAC still stalled on lung cancer drug
14 December 2021 - Lung cancer sufferers are still waiting on PHARMAC to reverse a decision made more than a year ago to freeze plans to fund drugs that could help at least 1,400 patients a year.
Advocates had been calling on the state drug buyer to fund Keytruda as a treatment for people with lung cancer.
